Filter
169
Filtered Results: 169
Text search:
Pharma-Ed
Featured
Recommendations
5
New Publications
42
Language
Document type
No document type
83
Studies & Reports
41
Guidelines
16
Training Material
13
Strategic & Response Plan
7
Manuals
5
Situation Updates
2
Resource Platforms
1
Fact sheets
1
Countries / Regions
India
11
Ethiopia
7
Kenya
7
Global
7
Philippines
5
Germany
5
Nigeria
4
Uganda
4
Burkina Faso
3
Ghana
3
South Africa
3
Malawi
3
Madagascar
3
Africa
3
Sierra Leone
2
Senegal
2
Haiti
2
Zambia
2
Tanzania
2
Indonesia
2
Bangladesh
2
Sudan
2
Ukraine
2
Liberia
1
Nepal
1
Syria
1
Cambodia
1
Benin
1
Central African Republic
1
Namibia
1
Eswatini/ Swaziland
1
Myanmar / Burma
1
Chile
1
Latin America and the Carribbean
1
Western and Central Europe
1
Paraguay
1
Authors & Publishers
Publication Years
Category
Countries
63
Clinical Guidelines
15
Women & Child Health
11
Public Health
10
Pharmacy & Technologies
7
Key Resources
4
Capacity Building
1
Toolboxes
Pharmacy
20
Mental Health
14
COVID-19
13
NCDs
13
HIV
9
AMR
9
Global Health Education
8
TB
5
NTDs
5
Caregiver
2
Health Financing Toolbox
2
Disability
1
Ebola
1
Natural Hazards
1
Rapid Response
1
Specific Hazards
1
Planetary Health
1
The African Centers for Disease Control and Prevention and the African Union together have called for a New Public Health Order which will safeguard the health and economic security of the continent as it strives to meet the aspirations of the Agenda 2063. A key pillar of this mandate seeks to expan...
Screening programmes for tuberculosis (TB) among immigrants rarely consider the heterogeneity of
risk related to migrants’ country of origin. We assess the performance of a large screening programme in asylum seekers by analysing (i) the difference in yield and numbers needed to screen (NNS) by c...
The aim of this article is to identify the elements behind the country’s successful COVID-19 rollout as well as lessons and chal lenges derived from this process. The analysis is relevant to many countries today—as they keep searching for strategies to cope with the second year of the COVID-19 p...
In 2014, an estimated 40 million women of reproductive age were infected with Schistosoma haematobium, S. japonicum and/or S. mansoni. In both 2003 and 2006, the World Health Organization (WHO) recommended that all schistosome-infected pregnant and breastfeeding women be offered treatment, with praz...
Health is essential in order to be able to lead a fulfilled and happy life. Health is not only a fundamental human right and one of the most valuable possessions any individual can have, it is also an essential prerequisite for social, economic and political development and stability. Health can onl...
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be major causes of premature death, disability and healthcare expenditure globally. Preventing the accumulation of cholesterol-containing atherogenic lipopr...
ABSTRACT
More than 500 million people worldwide live with cardiovascular disease (CVD). Health systems today face fundamental challenges in delivering optimal care due to ageing populations, healthcare workforce constraints, financing, availability and affordability of CVD medicine, and service del...
Introduction Pharmacovigilance (PV) systems to monitor drug and vaccine safety are often inadequate in sub-Saharan
Africa. In Malawi, a PV enhancement initiative was introduced to address major barriers to PV.
Objective The objective of this initiative was to improve reporting of adverse events (A...
Le profil pharmaceutique du pays présente des données sur les conditions socioéconomiques existantes et celles de la santé, les ressources, les structures règlementaires, les processus et les résultats relatifs au secteur pharmaceutique au Burkina-Faso. Ce document a pour but de compiler toute...
